Market Closed -
Nasdaq
21:00:00 08/05/2024 BST
|
5-day change
|
1st Jan Change
|
2.66
USD
|
-1.12%
|
|
-15.82%
|
+4.72%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
-
|
300
|
97.13
|
424.4
|
451.2
|
-
|
-
|
Enterprise Value (EV)
1 |
-
|
101.8
|
-41.42
|
300.5
|
317.4
|
296.8
|
451.2
|
P/E ratio
|
-5.69
x
|
-2.74
x
|
-1.2
x
|
-21.2
x
|
-266
x
|
53.6
x
|
29.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
2.64
x
|
0.81
x
|
2.83
x
|
2.39
x
|
2.03
x
|
1.67
x
|
EV / Revenue
|
-
|
0.9
x
|
-0.35
x
|
2
x
|
1.68
x
|
1.34
x
|
1.67
x
|
EV / EBITDA
|
-
|
-1.67
x
|
0.71
x
|
-22.2
x
|
50.4
x
|
22
x
|
-
|
EV / FCF
|
-
|
-1,533,579
x
|
674,228
x
|
-18,164,492
x
|
-
|
15,661,958
x
|
16,713,252
x
|
FCF Yield
|
-
|
-0%
|
0%
|
-0%
|
-
|
0%
|
0%
|
Price to Book
|
-
|
1.58
x
|
0.77
x
|
3.53
x
|
3.69
x
|
3.37
x
|
-
|
Nbr of stocks (in thousands)
|
-
|
152,307
|
159,150
|
167,095
|
169,640
|
-
|
-
|
Reference price
2 |
10.81
|
1.970
|
0.6103
|
2.540
|
2.660
|
2.660
|
2.660
|
Announcement Date
|
06/04/21
|
22/02/22
|
21/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
113.7
|
119.6
|
150
|
188.6
|
222.1
|
269.7
|
EBITDA
1 |
-
|
-60.87
|
-58.67
|
-13.53
|
6.3
|
13.5
|
-
|
EBIT
1 |
-
|
-93.92
|
-83.16
|
-23.21
|
-3.8
|
-
|
-
|
Operating Margin
|
-
|
-82.63%
|
-69.55%
|
-15.47%
|
-2.01%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-62.7
|
-79.42
|
-18.96
|
-
|
-
|
-
|
Net income
|
-22.37
|
-62.74
|
-79.67
|
-19.18
|
-
|
6.9
|
-
|
Net margin
|
-
|
-55.2%
|
-66.63%
|
-12.78%
|
-
|
3.11%
|
-
|
EPS
2 |
-1.900
|
-0.7200
|
-0.5100
|
-0.1200
|
-0.0100
|
0.0497
|
0.0900
|
Free Cash Flow
|
-
|
-66.37
|
-61.43
|
-16.54
|
-
|
18.95
|
27
|
FCF margin
|
-
|
-58.39%
|
-51.37%
|
-11.03%
|
-
|
8.54%
|
10.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
140.39%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
274.68%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/04/21
|
22/02/22
|
21/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
26.36
|
29.17
|
30.15
|
29.84
|
29.33
|
30.24
|
33.34
|
35.64
|
38.65
|
42.42
|
45.42
|
45.4
|
47.01
|
50.73
|
52.9
|
EBITDA
1 |
-20.85
|
-17.56
|
-18.41
|
-16.96
|
-15.46
|
-8.869
|
-6.43
|
-4.704
|
-2.8
|
-0.306
|
0.774
|
1.1
|
1.5
|
3
|
2.3
|
EBIT
1 |
-25.23
|
-28.58
|
-21.21
|
-21.07
|
-19.85
|
-21.03
|
-9.039
|
-6.408
|
-5.179
|
-2.583
|
-1.679
|
-1.4
|
-1
|
-
|
-
|
Operating Margin
|
-95.71%
|
-97.96%
|
-70.34%
|
-70.59%
|
-67.68%
|
-69.54%
|
-27.11%
|
-17.98%
|
-13.4%
|
-6.09%
|
-3.7%
|
-3.08%
|
-2.13%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
1.516
|
-21.05
|
-20.34
|
-22.93
|
-17.97
|
-18.18
|
-8.615
|
-
|
-4.4
|
-1.253
|
-1.301
|
-
|
-
|
-
|
-
|
Net income
1 |
1.505
|
-21.07
|
-20.36
|
-23.02
|
-17.98
|
-18.31
|
-8.758
|
-4.704
|
-4.414
|
-1.306
|
-1.466
|
-0.901
|
-0.545
|
-0.453
|
-
|
Net margin
|
5.71%
|
-72.22%
|
-67.53%
|
-77.14%
|
-61.31%
|
-60.54%
|
-26.27%
|
-13.2%
|
-11.42%
|
-3.08%
|
-3.23%
|
-1.98%
|
-1.16%
|
-0.89%
|
-
|
EPS
2 |
0.0100
|
-0.1400
|
-0.1300
|
-0.1500
|
-0.1100
|
-0.1100
|
-0.0500
|
-0.0300
|
-0.0300
|
-0.0100
|
-0.0100
|
-
|
-
|
-
|
0.008500
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/11/21
|
22/02/22
|
03/05/22
|
08/08/22
|
08/11/22
|
21/02/23
|
02/05/23
|
27/07/23
|
02/11/23
|
22/02/24
|
07/05/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
198
|
139
|
124
|
134
|
154
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-66.4
|
-61.4
|
-16.5
|
21
|
19
|
27
|
ROE (net income / shareholders' equity)
|
-
|
-61.3%
|
-49.8%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
1.250
|
0.7900
|
0.7200
|
0.7200
|
0.7900
|
-
|
Cash Flow per Share
2 |
-
|
-0.7600
|
-0.3900
|
-0.1000
|
0.1300
|
0.1200
|
-
|
Capex
1 |
-
|
0.66
|
0.35
|
0.15
|
3.04
|
3.64
|
4.32
|
Capex / Sales
|
-
|
0.58%
|
0.29%
|
0.1%
|
1.61%
|
1.64%
|
1.6%
|
Announcement Date
|
06/04/21
|
22/02/22
|
21/02/23
|
22/02/24
|
-
|
-
|
-
|
Last Close Price
2.66
USD Average target price
4
USD Spread / Average Target +50.38% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.72% | 451M | | +36.52% | 2.61B | | -43.39% | 2.07B | | +115.18% | 703M | | -65.23% | 154M |
Telemedicine Services
|